Home › Pathways › Women's Health Clinical Trials
♀️

Women's Health Clinical Trials

Women's health conditions have historically been under-researched, but clinical trials are beginning to close this gap. From endometriosis to breast and ovarian cancer, UK trials are exploring new treatments specifically designed for conditions that predominantly affect women.

8 Conditions 1 Treatments 1 Comparisons

Endometriosis: A Research Priority

Endometriosis affects 1 in 10 women in the UK, yet diagnosis still takes an average of 8 years. Clinical trials are testing new diagnostic biomarkers, anti-inflammatory treatments, GnRH antagonists that manage pain without menopausal side effects, and surgical techniques. The NHS has committed to accelerating endometriosis research through dedicated trial networks.

Breast and Ovarian Cancer Trials

The UK has one of the world's most active breast cancer trial programmes. PARP inhibitor trials are particularly relevant for women with BRCA mutations, offering targeted treatment for both breast and ovarian cancer. Trials also explore risk-reduction strategies for women with strong family histories, including preventive medication and enhanced surveillance protocols.

Closing the Gender Data Gap

Historically, clinical trials disproportionately studied men, leading to gaps in understanding how treatments work in women. Modern trials are required to include diverse populations, and many women's health trials specifically investigate sex-based differences in treatment response, drug metabolism, and disease progression.

📋 Conditions

💊 Treatments

⚖️ Comparisons

📰 Related Articles

Frequently Asked Questions

Can I join a clinical trial if I am pregnant?
Some trials specifically recruit pregnant women to test treatments for conditions like pre-eclampsia, gestational diabetes, and hyperemesis gravidarum. However, most general clinical trials exclude pregnant women for safety reasons. Always inform the trial team if you are pregnant or planning pregnancy.
Are there trials for BRCA mutation carriers?
Yes. Several UK trials focus on BRCA1 and BRCA2 mutation carriers, testing risk-reduction strategies, screening protocols, and targeted treatments like PARP inhibitors. Your genetics counsellor or oncologist can refer you to appropriate trials.

Find Your Clinical Trial

Search thousands of actively recruiting trials across the UK — free, instant, no registration.

Search Trials Now Read the Guide